Interleukin-2-induced splenic enlargement

Splenomegaly in patients with cancer raises the suspicion of tumor involvement. Splenic enlargement in the absence of splenic metastases, however, has been reported in patients treated with interleukin-2 (IL-2) immunotherapy. This study characterizes the change in spleen size that occurred in 42 pat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer 1995-06, Vol.75 (11), p.2737-2741
Hauptverfasser:	POZNIAK, M. A, CHRISTY, P. S, ALBERTINI, M. R, DUFFEK, S. M, SCHILLER, J. H
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Biological and medical sciences Drug toxicity and drugs side effects treatment Female Granulocyte-Macrophage Colony-Stimulating Factor - therapeutic use Humans Immunotherapy - adverse effects Interleukin-2 - adverse effects Male Medical sciences Middle Aged Pharmacology. Drug treatments Splenomegaly - etiology Splenomegaly - pathology Toxicity: blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!